1. Home
  2. PSTV vs HUGE Comparison

PSTV vs HUGE Comparison

Compare PSTV & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • HUGE
  • Stock Information
  • Founded
  • PSTV 1996
  • HUGE 1998
  • Country
  • PSTV United States
  • HUGE Canada
  • Employees
  • PSTV N/A
  • HUGE N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSTV Health Care
  • HUGE Health Care
  • Exchange
  • PSTV Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • PSTV 9.9M
  • HUGE 7.8M
  • IPO Year
  • PSTV N/A
  • HUGE N/A
  • Fundamental
  • Price
  • PSTV $1.75
  • HUGE $0.14
  • Analyst Decision
  • PSTV Strong Buy
  • HUGE
  • Analyst Count
  • PSTV 1
  • HUGE 0
  • Target Price
  • PSTV $8.00
  • HUGE N/A
  • AVG Volume (30 Days)
  • PSTV 64.4K
  • HUGE 2.6M
  • Earning Date
  • PSTV 08-12-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • PSTV N/A
  • HUGE N/A
  • EPS Growth
  • PSTV N/A
  • HUGE N/A
  • EPS
  • PSTV N/A
  • HUGE N/A
  • Revenue
  • PSTV $6,084,000.00
  • HUGE N/A
  • Revenue This Year
  • PSTV $5.21
  • HUGE N/A
  • Revenue Next Year
  • PSTV N/A
  • HUGE N/A
  • P/E Ratio
  • PSTV N/A
  • HUGE N/A
  • Revenue Growth
  • PSTV 733.42
  • HUGE N/A
  • 52 Week Low
  • PSTV $0.97
  • HUGE $0.13
  • 52 Week High
  • PSTV $3.21
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 47.92
  • HUGE 35.95
  • Support Level
  • PSTV $1.62
  • HUGE $0.14
  • Resistance Level
  • PSTV $1.92
  • HUGE $0.16
  • Average True Range (ATR)
  • PSTV 0.18
  • HUGE 0.01
  • MACD
  • PSTV 0.02
  • HUGE 0.01
  • Stochastic Oscillator
  • PSTV 52.24
  • HUGE 33.57

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: